Jovan Ugarkovic

Jovan Ugarkovic

Auto-generated profile, based on publicly available information

Jovan Ugarkovic

University of Novi Sad, Faculty of Medicine, Novi Sad + University Clinical Center of Vojvodina, Clinic of Obstetrics and Gynecology, Novi Sad

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Medicinski Pregled
Verified
Journal Article
Open access
PDF file
MSMarko Sinisa Stojic
Marko Sinisa Stojic
MPMilos Pantelic
Milos Pantelic
JUJovan Ugarkovic
Jovan Ugarkovic
GNGabriel-Stefan Nadj
Gabriel-Stefan Nadj
AIAleksandra Ilić
Aleksandra Ilić
Introduction. Vulvar carcinoma is a rare gynecological malignancy, accounting for 0.6 percent of all female cancers. Case Report. A-76-year-old woman presented with a tumorous lesion in the lower third of the left labia majora and minora, measuring approximately 25 mm. A multifocal biopsy was conducted, and pelvic magnetic resonance imaging revealed slight enlargement of a left inguinal solid lymph node. The patient underwent a left hemivulvectomy with inguinofemoral lymphadenectomy. Histopathological analysis confirmed a malignant lentiginous tumor, and inguinofemoral lymphadenectomy revealed metastatic malignant melanoma. Despite a negative histopathological finding of the contralateral side during the initial biopsy, the patient returned within three months with a 9-mm mucosal nodular type melanoma on the lower third of the right labia majora. A wide excision of the vulva was subsequently performed. Following consultation with a multidisciplinary tumor board, adjuvant immunotherapy with Pembrolizumab (200 mg per cycle, 9 cycles) was initiated. Conclusion. Vulvar malignant melanoma is rare, aggressive, and unpredictable tumor that predominantly affects women in later life. It is associated with a high recurrence rate and a poor overall prognosis.